---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-000614"
form_type: "8-K/A"
ticker: "ACH"
cik: "0000075252"
company_name: "ACCENDRA HEALTH INC/VA/"
filed_at: "2026-01-05T23:59:59+00:00"
generated_at: "2026-05-16T11:45:58.601008+00:00"
event_type: "m_and_a"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Accendra Health closes P&HS sale for $375M cash; pro forma revenue falls to $2.68B

## Summary
- Sold P&HS business for $375M cash on Dec 31, 2025; proceeds used to repay $280M current debt.
- Pro forma 2024 revenue $2.68B (vs $10.7B reported); net loss pro forma $366.5M vs $362.7M.
- Pro forma diluted EPS: 2024 -$4.78, 2023 -$0.15, 2022 -$0.72.
- Amended Receivables Sale Program: sold $94M eligible receivables, removed $160M intercompany payable.
- Retained a 5% equity interest in buyer with potential for up to $200M of priority distributions.

## SEC filing metadata
- accession: 0001104659-26-000614
- form_type: 8-K/A
- ticker: ACH
- cik: 0000075252
- company_name: ACCENDRA HEALTH INC/VA/
- filed_at: 2026-01-05T23:59:59+00:00
- event_type: m_and_a
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/75252/000110465926000614/0001104659-26-000614-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/75252/000110465926000614/omi-20251224x8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-000614
- JSON: https://secwatch.observer/filing/0001104659-26-000614.json
- Plain text: https://secwatch.observer/filing/0001104659-26-000614.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.